Devon Park Associates
Latest statistics and disclosures from Devon Park Associates's latest quarterly 13F-HR filing:
- Top 5 stock holdings are Inotek Pharmaceuticals, and represent 100.00% of Devon Park Associates's stock portfolio.
- Devon Park Associates has $31M in assets under management (AUM), dropping by 27.42%.
- Central Index Key (CIK): 0001610920
Portfolio Holdings for Devon Park Associates
Devon Park Associates holds 1 positions in its portfolio as reported in the September 2016 quarterly 13F filing
| Company (Ticker) | Portfolio Weight | Valued At | Change in Shares | Share Count | Share Price | |
|---|---|---|---|---|---|---|
| Inotek Pharmaceuticals | 100.0 | $31M | 3.2M | 9.48 |
|
Past Filings by Devon Park Associates
SEC 13F filings are viewable for Devon Park Associates going back to 2014
- Devon Park Associates 2016 Q3 filed Nov. 14, 2016
- Devon Park Associates 2016 Q2 filed Aug. 15, 2016
- Devon Park Associates 2016 Q1 filed May 3, 2016
- Devon Park Associates 2015 Q4 filed Feb. 9, 2016
- Devon Park Associates 2015 Q3 filed Nov. 16, 2015
- Devon Park Associates 2015 Q2 filed Aug. 14, 2015
- Devon Park Associates 2015 Q1 filed May 13, 2015
- Devon Park Associates 2014 Q4 filed Feb. 13, 2015